HHMI: Bitterness Remains

WASHINGTON—Behind Donald Fredrickson's forced resignation June 2 as president and lifetime trustee of the Howard Hughes Medical Institute lies a tale of budget overruns and unorthodox purchasing procedures that HHMI trustees and officials say stem from his wife's active and inappropriate role at the institute. "It's big and it's bad," said HHMI chairman George Thorn about the results of the six-month review conducted by the New York law firm of Paul, Weiss, Rifkind, Wharton & Garrison, abo

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"It's big and it's bad," said HHMI chairman George Thorn about the results of the six-month review conducted by the New York law firm of Paul, Weiss, Rifkind, Wharton & Garrison, about which he declined to provide details. Thorn is serving as acting chief executive officer while a search continues for a new president.

Fredrickson, a former NIH director, has a sharply different view of the events that led to his departure from the $5 billion institute that he had headed since 1984. An investigation into "rumors" that his wife, Henrietta, had too large a role in HHMI activities soon mushroomed into brutal personal questioning that made it "impossible [for me] to go back," he said.

Fredrickson acknowledges that one item that came under scrutiny is a $2.5 million cost overrun in a $12.5 million project to renovate the Cloisters, a former convent on the NIH campus being converted into ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ron Cowen

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours